A Double-blind, Randomized, Placebo-controlled, Multicenter Trial Evaluating the Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in Adult Patients With Non-constipated Irritable Bowel Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07168434

Title field or adapter rule

{'original_value': 'A Double-blind, Randomized, Placebo-controlled, Multicenter Trial Evaluating the Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in Adult Patients With Non-constipated Irritable Bowel Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:35.583711+00:00

Published At

2025-11-18T00:00:00+00:00

Record Updated At

2025-11-18

Source Retrieved At

2026-10-31T22:18:52.668840+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["IBS (Irritable Bowel Syndrome)", "IBS-D (Diarrhea-predominant)", "IBS, Mixed Symptoms"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2025-11-18", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07168434"

protocolSection.identificationModule.officialTitle

"A Double-blind, Randomized, Placebo-controlled, Multicenter Trial Evaluating the Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in Adult Patients With Non-constipated Irritable Bowel Syndrome"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• IBS (Irritable Bowel Syndrome) (protocolSection.conditionsModule.conditions)
• IBS-D (Diarrhea-predominant) (protocolSection.conditionsModule.conditions)
• IBS, Mixed Symptoms (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Treatment'], 'description': 'Saccharomyces boulardii CNCM I-745, 250 mg, 2 capsules/day', 'name': 'Saccharomyces Boulardii 250 MG', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo'], 'description': 'Placebo, 250mg, 2 capsules/day', 'name': 'Placebo 250 mg', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Saccharomyces Boulardii 250 MG (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo 250 mg (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.